Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Orexo (OX-CLI Project)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A leukotriene C4 synthase inhibitor program. The project aims to develop drugs to treat respiratory disorders such as asthma and chronic obstructive pulmonary disease.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare
Acquirer
Primary Office
  • Uppsala
  • Sweden

Orexo (OX-CLI Project) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Orexo (OX-CLI Project)‘s full profile, request access.

Request full access to PitchBook

Orexo (OX-CLI Project) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Orexo (OX-CLI Project)‘s full profile, request access.

Request full access to PitchBook